Chris Cooper

Work Performance Price Targets & Ratings Chart

Analyst Chris Cooper works at GOLDMAN SACHS

Most recent stock forecast was given on RMD, ResMed at 12-Apr-2024.

Wall Street Analyst Chris Cooper

Analyst best performing recommendations are on RMD (RESMED).
RMD ResMed

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

224

$36.24 (19.30%)

215

11 days ago

5/7 (71.43%)

$34.68 (18.32%)

371

Buy

215

$27.24 (14.51%)

215

16 days ago

7/11 (63.64%)

$18.67 (9.51%)

66

Buy

205

$17.24 (9.18%)

185

2 months 13 days ago

5/11 (45.45%)

$14.1 (7.39%)

88

164

$-23.76 (-12.65%)

158

2 months 18 days ago

4/6 (66.67%)

$-21.88 (-11.77%)

30

Buy

207

$19.24 (10.25%)

2 months 18 days ago

4/5 (80%)

$21.12 (11.36%)

60

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?